RecruitingPhase 3NCT06230445

Effects of Digital Therapeutic in Whole Process Management of Lung Cancer

A Phase 3, Randomized, Open-label Trial of Digital Therapeutic vs Regular Follow-up in Whole Process Management of Lung Cancer


Sponsor

Sun Yat-sen University

Enrollment

900 participants

Start Date

Jun 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This trial will randomize patients into two groups, the treatment group will use the digital therapeutic application named 'UHealth' for the whole process management and the control group will use regular follow-up. The trial aims to look into the difference between quality of life, anxiety/depression index, emergency treatment times, hospital admission rate, treatment compliance, OS, DFS and follow-up cost.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a digital therapeutic app designed to help patients with lung cancer manage their health throughout their treatment journey, including surgery, chemotherapy, radiation, targeted therapy, and immunotherapy. **You may be eligible if...** - You have confirmed lung cancer (histologically or by biopsy) - You have received or are currently undergoing any form of lung cancer treatment - You are between 18 and 70 years old - You or your family members are comfortable using a smartphone and the internet - You are in good functional condition (ECOG 0-1) **You may NOT be eligible if...** - Your cancer is currently progressing during the screening period - You have symptomatic brain metastases - You have dementia, schizophrenia, or other cognitive/psychological conditions - You have other significant medical or mental health conditions that prevent participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERUHealth digital therapeutic

UHealth digital therapeutic is an application that patients can report their symptoms. If the contents that patients fill in reach the threshold, UHealth application will automatic report to doctor and the doctor will give medical advisement through UHealth digital therapeutic application.


Locations(1)

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06230445